PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27866977-7	2017	It showed that QYD and swertiamarin ameliorated the testosterone-induced prostatic hyperplasia and collagen deposition, attenuated the over-expressions of HIF-1alpha, VEGF, EGF, betaFGF, PCNA, AR and ER-alpha, reduced the ratio of Bcl-2/Bax, enhanced the expression of ER-beta, inhibited the oxidative stress and local inflammation, as well as relieved prostatic EMT.	swertiamarin	23-35	proliferating cell nuclear antigen	Rattus norvegicus	187-191